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Natural killer (NK) cells capable of spontaneous lysis of tumor cells, and killer (K) 
cells  that  can  lyse  antibody-coated  target  cells  have  been  demonstrated  in  many 
species (1-3). Much attention has been focused on these cells because of their possible 
role in  the elimination of tumors  and  virus-infected cells (1).  Although  NK  and  K 
cells have been characterized as "non-T, non-B cells" because they are not generated 
in  the thymus  and  do not  express the usual  array of T  and  B  cell surface markers, 
their cell lineage remains  an  enigma.  In  humans,  NK  activity has  been  associated 
with a  population of large granular lymphocytes (4, 5). NK cells are largely acquired 
after birth  in rodents and  pigs, but  limited and conflicting information  is available 
with  regard to their ontogeny  in humans  (4,  6-9).  In the earlier studies NK and  K 
cells were defined primarily by their functional properties. 
We have recently produced a  monoclonal IgM antibody (HNK-1)  that identifies a 
discrete population of lymphoid cells in humans with NK and K  cell activities (10). 
In the experiments reported here, HNK-1  antibody was used to enumerate NK and 
K  cells in human  blood as a  function of age and sex;  NK and K  cell activities were 
examined in parallel. 
Materials  and  Methods 
Cell  Preparation.  Mononuclear  cells  from  heparinized  peripheral  blood of neonates  and 
healthy adult  donors were  isolated by FiColl-Hypaque (Pharmacia  Fine Chemicals, Div.  of 
Pharmacia Inc., Piscataway, N. J.)  density gradient  (10).  The cells were washed three times 
with RPMI  1640 with  10% heat-inactivated fetal calf serum and 50/~g/ml gentamycine and 
suspended in this medium. 
HNK-I  Monoclonal Antibody.  HNK-1  is an  IgM monoclonal antibody produced against a 
membrane extract of a human lymphoblastoid cell line (HSB-2) as previously described (10). 
This reagent will be available through the Becton, Dickinson & Co., Mountain View, Calif,, 
and the American Type Culture Collection, Rockville, Md. 
Immunofluorescence Assays.  Cells reactive with a monoclonal antibody, HNK- 1, were enumer- 
ated  by  an  indirect  immunofluorescence  assay  (10).  The  HNK-1  antibody was  used  at  a 
concentration of 10 ~g/ml for detection of both surface and cytoplasmic expression of HNK-1 
antigen. Secondary antibodies were fluorescein isothiocyanate-conjugated (FITC) and tetra- 
methyrhodamine isothiocyanate-conjugated (RITC)  goat anti-mouse/~ chain antibody (gen- 
erously supplied by  Dr.  W.  E.  Gathing,  University of Alabama in  Birmingham)  (11).  The 
procedure for staining was performed as described elsewhere (10,  11). 
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Age  of  Donors 
Fla.  1.  Age-related increase of HNK-I  + ceils in peripheral blood of healthy donors. The frequency 
ofHNK-I  + cells among mononuc[ear cells was determined in blood samples from 54 males (O) and 
58  females (Q)  ranging in age from the day of birth to 88  yr. HNK-1 + cells were enumerated by 
indirect  membrane immunofluorescence using HNK-I monoctonal IgM antibody and FITC-anti- 
mouse/~. 
Natural Killer Assay.  NK cell  function was examined by a 51Cr-specific release  assay using 
K562 target cells as described previously (10). Briefly,  100 ~1 of labeled 104 K562 was incubated 
with  100 #1 of effector cells  at  ratios  from  1:1.25  to  1:20  for 6  h  at  37°C  in  a  humidified 
atmosphere containing 5% CO2 in air. The percentage of SlCr-specific  release  =  2S/M ×  100, 
where S is the count of 100/~1 of supernatant and M  is the average count of maximum release 
from the  labeled  target cells.  Percentages of spontaneous release  without effector cells  were 
<5.0%. All samples were assayed in triplicate cultures. 
Results  and Discussion 
The monoclonal HNK-1 antibody was previously shown to react selectively with a 
discrete subpopulation of lymphoid cells with NK and K  cell activities (10). Approx- 
imately  90%  of the  HNK-1 + cells  express  surface  receptors  for IgG antibodies  and 
contain azurophilic granules in their neutrophilic cytoplasm; some bind sheep eryth- 
rocytes to form rosettes, whereas others do not. 
HNK-1 + cells were enumerated  in a  group of 112  normal subjects who ranged in 
age from the day of birth to 88 yr. We found a highly significant correlation between 
age and HNK-1 antigen expression  (r =  0.78, P <  0.0001). Among mononuclear cells 
in blood, the percentage of HNK-1 + cells was only 0.5  +  0.3% in  13 newborns  (Fig. 
1). This proportion increased with age so that HNK-1 + cells comprised 5.1  +  3.5% of 
circulating mononuclear cells in 21 children <15,  12.3 +  5.1% in 29 individuals aged 
15-30, and 22.2 +  9.6% in 49 adults >30 yr old. 
When  the  relationship  between  HNK-1 + cell  frequencies  and  NK cell  functional 
activity  was  examined,  an  increased  proportion  of  HNK-1 +  cells  was  found  to 
correspond with an increased  level of NK cell activity  (Fig.  2).  This correlation  was 
most striking when comparing groups of newborns, children, and young adults. Even 
among older  individuals,  such  as  those  in  the  6th  and  7th  decade,  a  relationship 
between  the  proportion  of HNK-I +  cells  and  NK  cell  activity  was  still  apparent, 
although the functional efficiency of NK cells appeared to be optimal in young adults 
(Fig.  2).  These  same  relationships  of antigen  expression  and  function  were  also 
observed in a  K  cell lytic assay using sensitized chicken erythrocytes as the target and 
nylon wool nonadherent  lymphocytes (to eliminate macrophages) as the effector cells 
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FIG.  2.  Relation of liNK-1 + cell frequencies, functional NK cell activity, and age. 
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FIG.  3.  Two-color immunofluorescent analysis of HNK-I antigen expression on the surface mem- 
brane and in the cytoplasm of adult blood mononuclear cells. (a)  Surface membrane expression of 
HNK-1 antigen (fluorescein stain) seen under incubation conditions favoring redistribution of cross- 
linked surface receptors (cells A, B, and C).  (b) Cytoplasmic HNK-1 expression (rhodamine stain) 
observed in cells A and B but not in cell C  (× 600). 324  ABO ET  AL.  BRIEF  DEFINITIVE REPORT 
In addition to HNK-1 expression on the surface membrane, we found a prominent 
cytoplasmic expression of HNK-1 antigen in some but not all cells (Fig. 3). Conversely, 
all of the cells with visible cytoplasmic expression of HNK-1 bore detectable HNK-1 
antigen on their surface. The cytoplasmic HNK-1 expression was most prominent in 
adult blood lymphocytes. In eight adults, a mean of 51% of the surface HNK-1 + cells 
were cytoplasmic HNK-1 +, whereas cytoplasmic expression was detectable in only 6% 
of HNK-1 + cells in blood samples  (n  =  6)  from newborns and young children.  We 
also observed that  few surface HNK-1 + cells in adult  bone marrow samples (n =  8) 
expressed cytoplasmic HNK-1  (mean,  18% positive). These observations suggest that 
cytoplasmic accumulation of HNK-1 molecules normally occurs in more mature cells 
of this lineage.  Elucidation  of the biologic significance of this awaits molecular and 
functional definition of the HNK-1 molecule. 
The age-related changes that we have defined in the postnatal expansion of human 
NK and K  cells are complementary to those previously observed in animals of other 
species. NK cell activity is not demonstrable during the first 2 wk of life in mice and 
rats  (1,  2,  12);  it  begins  to  appear between  2  and  3  wk of age,  then  increases  to 
maximum  levels  between  the  5th  and  8th  wk.  A  delayed  appearance  of NK cell 
function  has  also  been  noted  in  pigs  (3).  In  a  previous study  in  humans,  no clear 
relationship  between  NK and  K  cell  functional  activity and  age was  noted  among 
individuals  20  yr of age  or  older  (6,  7).  Other  investigators,  using  NK  or  K  cell 
functional assays, have obtained results suggestive of a  lower level of NK and K  cell 
activities  in  blood cells  from children  compared with  adults  (4,  8,  9).  The present 
results  clearly show  this  to  be the  case, and  suggest  that  the  basis  for the  relative 
deficiency of NK and K  cell activities in young humans is due to a  numerical deficit 
of the cells with NK and K  activities. In support of this conclusion, we observed in 
newborn  blood  a  low  frequency  (<1.2%  of  mononuclear  cells)  of  medium-sized 
lymphocytes with azurophilic  granules  using the  May-Gr~inwald-Giemsa stain.  Al- 
though  there is a  correlation between  NK function  and HNK-1  antigen expression, 
there appears to be comparatively higher killing activity in cord blood (13,  14)  than 
expected from the result of fewer proportion of HNK-1 + cells. In the functional assay 
using K562, cells other than NK cells may act as effector cells in cord blood, because 
analogues of NK cells have recently been associated with  the killing of K562  (15). 
This issue is under investigation by cell sorting analysis using HNK-1 antibody. 
With  increasing age, an  inverse relationship with  NK function  has been demon- 
strated  in  mice, with  functional  NK cell activity declining  progressively beyond  12 
wk of age (1, 2). Although we did not observe such a prominent age-related decrease 
in  the level of NK function  in  humans,  there was a  broader range of HNK-1 + cell 
levels in older individuals (Fig.  1), and efficient NK activity was not always correlated 
with  a  higher frequency of HNK-1 + cells  (Fig.  2).  This raises the possibility that  a 
dissociation between expression of HNK-1 antigen and NK cell function might exist 
in some elderly individuals.  It is also conceivable that human NK cells are HNK-1 
positive (10) but not all HNK-1 + cells are associated with killing of a particular target 
cell, because earlier studies using single cell agarose NK assay (16)  and plaque K  cell 
assay  (17)  indicated  that  only  1-5%  of mononuclear  cells were  responsible  for the 
above activities. 
In addition  to  the  correlation  with  age,  we  noted  a  correlation  of HNK-1 + cell 
levels with  the sex of the donor.  A  significantly higher  proportion of HNK-1 + cells ABO ET AL.  BRIEF  DEFINITIVE REPORT  325 
was  observed  among 54  males  than  among 58  females  (16.9  vs.  13.1%,  P  <  0.05) 
whose ages were comparable (mean ages: 30.2 vs. 32.1  yr). The slightly higher level 
of HNK-1  + cells  in males is in agreement with the findings of other investigators (4, 
18,  19), who noted a  lower level of NK or K  cell function in females. It thus appears 
that  sex  hormones may influence the  development of NK cells  in  humans.  Such a 
hypothesis  is  supported  by the  demonstration  that  estrogen  administration  blocks 
maturation of NK cells  in mouse bone marrow, although a  nonphysiological dose of 
estrogen was administered in the study (20). 
Although we have consistently observed HNK-1 + cells  in  15-17-wk fetuses  (0.05- 
0.2%  of cells  in  liver,  spleen,  and  thymus),  relatively  few  HNK-1 + cells  appear  to 
enter  the  circulation  by birth.  This  retarded  developmental  pattern,  while  as  yet 
unexplained,  may be unique for NK and  K  cells  among blood cell  types, since the 
proportions  of T  and  B  lymphocytes,  monocytes, and  granulocytes  have  already 
reached adult levels at birth. 
Summary 
Human natural  killer  (NK)  and killer  (K)  cells  were directly enumerated using a 
monoclonal antibody (HNK-1 ) and an immunofluorescence assay. The frequency of 
cells  bearing  surface  HNK-1  antigen  was  very  low  in  the  newborn  (<1.0%)  and 
increased  progressively through childhood and  into  adult  life.  This  was  correlated 
with  an  age-related  increase  in  functional  NK  and  K  cell  activities.  Males  had  a 
slightly  higher  proportion  of HNK-1 +  cells  than  females.  In  addition  to  HNK-1 
expression on the surface membrane, a  prominent cytoplasmic expression of HNK-1 
antigen  was  found  in  some  but  not  all  surface  HNK-1 +  cells.  The  cytoplasmic 
accumulation of HNK-1  molecules appeared  to occur in  more mature cells  of this 
lineage. 
We thank Dr. John F. Kearney for his generous assistance in the production of this monoclonal 
antibody and Linda Gjellum for help in preparation of the manuscript. 
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